Sponsored by
For the Inventor. By the Inventor. With the Investor.
We curate this newsletter based on Patent Strength, a metric of a patent’s strategic value and its legal ability to withstand challenges.
Table of Contents
Breakthroughs - Companies covered
Becker Transactions (Frederick R. Guy Portfolio) — An intellectual property brokerage commercializing ambient, open-air non-thermal plasma deposition technology for medical and semiconductor applications.
Clearmind Medicine (NASDAQ: CMND) — A clinical biotech firm expanding its IP umbrella into dynamic, cable-free wireless charging infrastructure for autonomous vehicles.
Niagen Bioscience (NASDAQ: NAGE) — A life sciences innovator developing targeted composition-of-matter NAD+ exposure therapeutics for rare pediatric genetic conditions.
Mitsubishi Gas Chemical & Veritas In Silico (TYO: 4182 / TYO: 130A) — A specialty chemical giant partnering with an in-silico RNA platform to pioneer long non-coding RNA cancer therapies.
Alpha Cash (Alpha Modus Holdings) (NASDAQ: AMOD) — A community FinTech engine deploying patented, closed-loop consumer AI frameworks for retail ad attribution.
MPH Technologies — An independent cybersecurity IP holder licensing foundational dynamic network tunneling and encrypted routing protocols.
Want your company featured to 50,000 plus innovation-minded readers? Sponsor an IDiyas story. Please see our newsletter stats. Send us an email to: [email protected] for details.
Newsletter published 3x weekly. Sign up by clicking on the image above.
Publishing a newsletter used to mean talking at an audience, but with over 50,000 active subscribers, we wanted true, bidirectional dialogue. Today, we’re launching the IDiyas Foundry to turn our one-way broadcast into an interactive conversation for the entire IP community.
🛡️Protect Your Invention
Ready to file? Get a fast, free quote from our network of registered practitioners.
Please click here.
Featured Sponsored Content
One Account. Every Market. No Closing Bell.
Markets don't wait for Monday. News breaks on a Saturday morning, and most traders can do nothing but watch.
Not on Liquid. Trade domestic and international equities, commodities, forex, crypto, and prediction markets — all from one account, 24 hours a day, 365 days a year. Liquid gives you access to any market, from anywhere, anytime. To us, access is arbitrage.
Getting started takes under 10 minutes: log in with Google, deposit with Apple Pay or a bank transfer, and trade from your phone or desktop — wherever you are in the world.
While everyone else is refreshing headlines and waiting for the open, you're already positioned. That's the difference between reacting to markets and actually trading them.
🧪 Materials & Advanced Physics
Becker Transactions’ Cold Plasma Wand
Attorney and inventor Frederick R. Guy placed his foundational non-thermal plasma deposition portfolio up for acquisition and licensing via Becker Transactions. The patent suite allows material to be deposited directly onto delicate substrates in open air without requiring a vacuum chamber.
🔬 The Tech: U.S. Patent Nos. 10,384,069 and 11,642,542, protecting a process that deposits materials (including powders, aerosols, and polymers) via a non-thermal plasma stream at dialed ambient temperatures, eliminating the traditional thermal damage of atmospheric plasma and the size constraints of vacuum chambers.
📈 Stock Ticker: Private (Becker Transactions / Frederick R. Guy Portfolio)
🏋️♂️ Patent Strength: 94
🚀 The Big Deal: Standard atmospheric plasma runs so hot it burns through biological tissue and thin-film electronics, while low-temperature plasma historically required cramming the subject inside a sealed vacuum box. This technology puts cold plasma deposition on a handheld wand, allowing surgeons to spray biological coatings onto living organs or technicians to repair delicate chips in open air.
🌊 The Domino Effect: Handheld non-thermal plasma wands reach commercial production → surgeons apply instant protective coatings to internal surgical wounds → post-operative infection and recovery times plummet worldwide.
⚡ Clean Energy & Wireless Infrastructure
Clearmind’s Cable-Free EV Charging Network
Clinical biotech firm Clearmind Medicine signed a letter of intent to acquire a 51% stake in an intelligent wireless EV charging provider, expanding its IP portfolio into autonomous mobility.
🔬 The Tech: Proprietary wireless power transfer technology featuring smart communication, dynamic energy management, and continuous cable-free charging up to 10 kW designed for automated parking garages and autonomous mobile platforms.
📈 Stock Ticker: NASDAQ: CMND
🏋️♂️ Patent Strength: 92
🔗 Source: GlobeNewswire - August 3, 2026
🚀 The Big Deal: Autonomous taxi swarms and robotic parking garages are useless if human attendants still have to manually plug in heavy charging cables. Locking up dynamic 10 kW wireless charging IP allows robotaxis to top off their batteries automatically while navigating parking structures.
🌊 The Domino Effect: Automated parking garages embed 10 kW wireless floor pads → autonomous fleet uptime increases by 35% → traditional plug-in charging stations are phased out of modern urban parking developments.
Sponsored content
The GTM Playbook Behind Warmly's Acquisition
Warmly ran pipeline, outreach, and lead scoring on autopilot for hundreds of startups — before a single sales hire.
HubSpot acquired them for it. Now the cofounders are walking you through the exact system, live, before they disappear into product. Join the Builder Session on August 12.
Leave with an agentic GTM stack you can replicate this week. Plus HubSpot Credits when you join HubSpot for Startups.
🧬 Life Sciences, Longevity & Oncology
Genflow’s Centenarian Youth Gene
Longevity pioneer Genflow Biosciences achieved major U.S. patent updates for its proprietary SIRT6 gene therapy platform aimed at reversing age-related metabolic decay.
🔬 The Tech: Published U.S. Patent Application No. 2026/0199524 A1 and granted Track One prioritized USPTO status for its centenarian-derived SIRT6 variant (SIRT6c; N308K/A313S) designed to treat non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
📈 Stock Ticker: LSE: GENF / OTCQB: GENFF
🏋️♂️ Patent Strength: 93
🚀 The Big Deal: Instead of telling patients to change their lifestyle or take daily metabolic pills, Genflow isolates the genetic sequence found in humans who naturally live past 100 and delivers it directly to the liver. Securing Track One status accelerates the legal moat protecting their centenarian biological sequence.
🌊 The Domino Effect: SIRT6c gene therapy passes clinical trials → metabolic liver disease is reversed at the cellular level → liver transplant waitlists dry up significantly.
Niagen Bioscience’s NAD+ Cellular Recharge
Niagen Bioscience partnered with Evotec to advance preclinical development for its lead rare-disease candidate, NB4168, backed by a fortified composition-of-matter patent portfolio.
🔬 The Tech: Proprietary composition-of-matter patents protecting oral NB4168, an investigational agent engineered to deliver increased nicotinamide riboside (NR) exposure directly into cells via the nicotinamide riboside kinase (NRK) pathway to restore cellular NAD+ levels.
📈 Stock Ticker: NASDAQ: NAGE / NASDAQ: EVO
🏋️♂️ Patent Strength: 91
🔗 Source: Business Wire - August 3, 2026
🚀 The Big Deal: You can't simply take generic wellness supplements to solve rare genetic pediatric disorders like Ataxia-Telangiectasia (A-T). By locking up composition-of-matter claims around a high-potency oral molecule, Niagen creates a protected therapeutic pathway for restoring DNA repair and cellular energy.
🌊 The Domino Effect: NB4168 completes IND-enabling studies → FDA grants accelerated approval for pediatric neurodegenerative indications → legacy symptom-management therapies lose their market share.
Sponsored content
The best voice models, now with full orchestration. Build real-time voice and chat agents on one low-latency stack: any LLM, your tools and knowledge, testing, Guardrails, and omnichannel deployment.
🤖 FinTech & Network Cyber-Defenses
Alpha Cash’s Retail AI Feedback Loop
Alpha Cash launched its Super Connector ecosystem, anchoring its financial platform to a patented closed-loop consumer AI framework.
🔬 The Tech: U.S. Patent-protected closed-loop retail AI framework ("Sense → Decide → Deliver → Attribute"), engineered to analyze physical interactions, digital media engagement, and financial transaction outcomes across a unified mobile network.
📈 Stock Ticker: NASDAQ: AMOD (Alpha Modus Holdings)
🏋️♂️ Patent Strength: 91
🔗 Source: GlobeNewswire - August 3, 2026
🚀 The Big Deal: Most FinTech apps show you advertisements and hope you make a purchase. Alpha Cash’s patented architecture tracks the entire sequence from digital view to physical store visit to final transaction settlement, giving brands exact attribution data.
🌊 The Domino Effect: Retailers integrate the Sense-Decide-Deliver-Attribute platform → digital ad waste drops to zero → legacy ad networks using estimated engagement metrics lose market share.
MPH’s Broad-Spectrum Tunneling Shield
The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a key ruling in favor of MPH Technologies against Apple Inc., expanding the legal interpretation of MPH's secure networking patents.
🔬 The Tech: U.S. Patent No. 7,937,581, protecting secure dynamic network connections and encrypted data routing protocols across mobile device ecosystems.
📈 Stock Ticker: NASDAQ: AAPL
🏋️♂️ Patent Strength: 96
🔗 Source: CAFC / Patently-O - August 3, 2026
🚀 The Big Deal: Apple argued that MPH's patent was restricted strictly to the legacy IPSec protocol. The Federal Circuit rejected that narrow view, giving MPH a vastly broader legal perimeter to assert patent tolls over modern secure mobile communications.
🌊 The Domino Effect: Federal Circuit broadens patent claims beyond IPSec → tech giants are forced to enter global licensing negotiations for mobile data tunneling → independent IP holding firms secure record royalty streams.
In the age of AI, answers are cheap. Great questions are the new currency.
So here's our challenge: ask us the one question about patents, inventors, or innovation you've always wanted answered. Which law firms quietly dominate AI patents? Which inventors are one filing away from the centurion club? What's the next semiconductor gold rush?
If we select your question, we'll turn it into a live data product on the Spartera marketplace. Your curiosity, transformed into intelligence that thousands of analysts, investors, and IP professionals can query.
And as the mind behind it, you'll get a free year of IDiyas Go Pro ($129 value) on us.
The best answers start with the best questions. What's yours?
The Patent Ticker: Because by the time it's on a shelf, the money's already been made.
The Fine Print: The inventors are busy, the investors are greedy, and the patents are rolling in. A patent today doesn’t guarantee a profit tomorrow. IDiyas is a data and information platform, not a financial advisor. While we love tracking innovation, this newsletter is for educational purposes only. Always conduct your own due diligence before making any financial moves.